Cargando...
Post-market safety warnings for drugs approved in Canada under the Notice of Compliance with conditions policy
AIMS: Health Canada has developed a pathway to approve drugs that have limited efficacy and safety data, the Notice of Compliance with conditions (NOC/c) policy. Increased safety reporting is required for these drugs but there has not been any systematic review of their post-market safety. This stud...
Guardado en:
| Publicado en: | Br J Clin Pharmacol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BlackWell Publishing Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4415721/ https://ncbi.nlm.nih.gov/pubmed/25393960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12552 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|